Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


July 31, 2015 8:07 AM ET

Biotechnology

Company Overview of Neovacs S.A.

Executive Profile

Miguel Sieler

Chief Executive Officer and Director, Neovacs S.A.
AgeTotal Calculated CompensationThis person is connected to 3 Board Members in 3 different organizations across 3 different industries.

See Board Relationships
--€183,214
As of Fiscal Year 2014

Background

Mr. Miguel Sieler serves as a Chief Executive Officer Circle, Life Sciences at Truffle Capital. Mr. Sieler focuses on life sciences. Earlier, he served as the Venture Partner at the firm. Mr. Sieler has been Chief Executive Officer at Neovacs S.A. since October 17, 2013 and its General Director since October 2013. He served as Chairman and Chief Executive Officer of Bayer France. Mr. Sieler served in various senior positions at Bayer Group from 1975 to 2008. He served ...

Corporate Headquarters

3-5, Impasse Reille
Paris, Ile-de-France 75014

France

Phone: 33 1 53 10 93 00
Fax: 33 1 53 10 93 03

Board Members Memberships

Director, Member of Audit & Accounts Committee and Member of Compensation & Appointments Committee
Chief Executive Officer and Director
Director and Member of Compensation Committee

Education

LLB
Eberhard Karls Universität Tübingen
LLB
Institut d'Etudes Politiques de Paris

Other Affiliations

Annual Compensation

Salary€143,712
Bonus€38,342
Total Annual Compensation€182,054

Stocks Options

All Other Compensation€1,160

Total Compensation

Total Annual Cash Compensation€183,214
Total Short Term Compensation€182,053
Other Long Term Compensation€1,160
Total Calculated Compensation€183,214
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Neovacs S.A., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.